Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Frontier Bio develops lab-grown human tissues using cutting-edge 3D bioprinting and stem cell technology as alternatives to animal testing and, ultimately, for organ transplantation. Their technology is already commercially deployed for research, medical device testing, and surgical training, but their lead vascular graft product is preclinical. They have successfully executed contracts with major medical device companies, academic institutions, and government agencies, with reported revenue growth and ongoing investor funding rounds[2][3][4].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Frontier Bio.